(Q44004469)

28 November 2017

Serum insulin and leptin levels in valproate-associated obesity (English)

1 reference

28 November 2017

0 references

1 reference

Mikael Knip

2

0 references

author name string

Virpi Pylvänen

1

1 reference

28 November 2017

Arto Pakarinen

3

1 reference

28 November 2017

Mervi Kotila

4

1 reference

28 November 2017

Jukka Turkka

5

1 reference

28 November 2017

Jouko I T Isojärvi

6

1 reference

28 November 2017

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

43

1 reference

28 November 2017

5

1 reference

28 November 2017

514-517

1 reference

Obesity and endocrine disorders in women taking valproate for epilepsy.

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Weight-reducing effects of the plasma protein encoded by the obese gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

The OB protein (leptin) pathway--a link between adipose tissue mass and central neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Valproate and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Metabolic changes during treatment with valproate in humans: implication for untoward weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.31501.X

10.1046/J.1528-1157.2002.31501.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference